1
|
Squitti R, Cerchiaro G, Giovannoni I, Francalanci P, Siotto M, Maffei P, Ricordi C, Rongioletti MC. A case of a mild Wolfram Syndrome with concomitant ATP7B mutation. CellR4 Repair Replace Regen Reprogram 2019; 7. [PMID: 33869661 DOI: 10.32113/cellr4_20198_2735] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Background Wolfram Syndrome 1 (WS1) has been characterized on the basis of mutation in the WFS1 gene encoding a calcium storage wolframin endoplasmatic reticulum transmembrane glycoprotein. Patients and Methods We observed a WS 10-years old female subject, with Type 1 diabetes-mellitus (DM), that had compound heterozygous WSF1 mutations but without other symptoms generally observed in WS subjects, such as optic atrophy or neurodegeneration. Results Decreased copper, ceruloplasmin, and transferrin levels, pointing to a copper deficiency, were associated with a new c.18703A>G mutation in the ATP7B gene, while lower calcium levels were associated with WSF1 mutations. An omega-3 fatty acids therapy was administrated to the subject in the attempt to ameliorate diabetes symptoms, restored copper deficiency, and normal calcium levels. Conclusions This specific case report provides new insights into the potential interplay of ATP7B mutation in shaping a milder WS clinical picture.
Collapse
Affiliation(s)
- R Squitti
- IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy
| | - G Cerchiaro
- Center of Natural Sciences and Humanities, Federal University of ABC - UFABC, Santo André, São Paulo, Brazil
| | - I Giovannoni
- Department of Pathology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - P Francalanci
- Department of Pathology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
| | - M Siotto
- IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy
| | - P Maffei
- Department of Medicine (DIMED), Clinica Medica 3, Padua University Hospital, Italy
| | - C Ricordi
- Diabetes Research Institute and Cell Transplant Center, University of Miami, Miami, FL, USA
| | - M C Rongioletti
- Department of Laboratory Medicine, Research and Development Division, 'San Giovanni Calibita', Fatebenefratelli Hospital, Isola Tiberina, Rome, Italy
| |
Collapse
|
2
|
Conte-Daban A, Boff B, Candido Matias A, Aparicio CNM, Gateau C, Lebrun C, Cerchiaro G, Kieffer I, Sayen S, Guillon E, Delangle P, Hureau C. A Trishistidine Pseudopeptide with Ability to Remove Both Cu Ι and Cu ΙΙ from the Amyloid-β Peptide and to Stop the Associated ROS Formation. Chemistry 2017; 23:17078-17088. [PMID: 28846165 PMCID: PMC5714062 DOI: 10.1002/chem.201703429] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2017] [Indexed: 01/08/2023]
Abstract
The pseudopeptide L, derived from a nitrilotriacetic acid scaffold and functionalized with three histidine moieties, is reminiscent of the amino acid side chains encountered in the Alzheimer's peptide (Aβ). Its synthesis and coordination properties for CuΙ and CuΙΙ are described. L efficiently complex CuΙΙ in a square-planar geometry involving three imidazole nitrogen atoms and an amidate-Cu bond. By contrast, CuΙ is coordinated in a tetrahedral environment. The redox behavior is irreversible and follows an ECEC mechanism in accordance with the very different environments of the two redox states of the Cu center. This is in line with the observed resistance of the CuΙ complex to oxidation by oxygen and the CuΙΙ complex reduction by ascorbate. The affinities of L for CuΙΙ and CuΙ at physiological pH are larger than that reported for the Aβ peptide. Therefore, due to its peculiar Cu coordination properties, the ligand L is able to target both redox states of Cu, redox silence them and prevent reactive oxygen species production by the CuAβ complex. Because reactive oxygen species contribute to the oxidative stress, a key issue in Alzheimer's disease, this ligand thus represents a new strategy in the long route of finding molecular concepts for fighting Alzheimer's disease.
Collapse
Affiliation(s)
- A. Conte-Daban
- CNRS, LCC (Laboratoire de Chimie de Coordination) 205 route de Narbonne,BP 44099 31077 Toulouse Cedex 4, France
- University of Toulouse, UPS, INPT 31077 Toulouse Cedex 4, France
| | - B. Boff
- Univ. Grenoble Alpes, CEA, CNRS, INAC, SyMMES (UMR 5819), CIBEST, 17 rue des martyrs, F-38 000 Grenoble, France
| | - A. Candido Matias
- Univ. Grenoble Alpes, CEA, CNRS, INAC, SyMMES (UMR 5819), CIBEST, 17 rue des martyrs, F-38 000 Grenoble, France
- Center for Natural Sciences and Humanities, Federal University of ABC – UFABC 09210-580, Santo André, SP, Brazil
| | - C. N. Montes Aparicio
- CNRS, LCC (Laboratoire de Chimie de Coordination) 205 route de Narbonne,BP 44099 31077 Toulouse Cedex 4, France
- University of Toulouse, UPS, INPT 31077 Toulouse Cedex 4, France
| | - C. Gateau
- Univ. Grenoble Alpes, CEA, CNRS, INAC, SyMMES (UMR 5819), CIBEST, 17 rue des martyrs, F-38 000 Grenoble, France
| | - C. Lebrun
- Univ. Grenoble Alpes, CEA, CNRS, INAC, SyMMES (UMR 5819), CIBEST, 17 rue des martyrs, F-38 000 Grenoble, France
| | - G. Cerchiaro
- Center for Natural Sciences and Humanities, Federal University of ABC – UFABC 09210-580, Santo André, SP, Brazil
| | - I. Kieffer
- BM30B/FAME beamline, ESRF, F-38043 Grenoble cedex 9, France
- Observatoire des Sciences de l’Univers de Grenoble, UMS 832 CNRS Université Grenoble Alpes, F-38041 Grenoble, France
| | - S. Sayen
- Institut de Chimie Moléculaire de Reims (ICMR, UMR CNRS 7312), Université de Reims Champagne-Ardenne, F-51687 Reims Cedex 2, France
| | - E. Guillon
- Institut de Chimie Moléculaire de Reims (ICMR, UMR CNRS 7312), Université de Reims Champagne-Ardenne, F-51687 Reims Cedex 2, France
| | - P. Delangle
- Univ. Grenoble Alpes, CEA, CNRS, INAC, SyMMES (UMR 5819), CIBEST, 17 rue des martyrs, F-38 000 Grenoble, France
| | - C. Hureau
- CNRS, LCC (Laboratoire de Chimie de Coordination) 205 route de Narbonne,BP 44099 31077 Toulouse Cedex 4, France
- University of Toulouse, UPS, INPT 31077 Toulouse Cedex 4, France
| |
Collapse
|
4
|
Kang H, Metz LM, Traboulsee AL, Eliasziw M, Zhao GJ, Cheng Y, Zhao Y, Li DKB, Traboulsee A, Li D, Riddehough A, Cheng Y, Lam K, Lee A, Zhao GJ, Vorobeychik G, Metz L, Yeung M, Yong VW, Hill M, Cerchiaro G, Ma C, Topor T, Blevins G, Marriott J, Kremenchutzky M, Freedman M, Lee L, Duquette P, Antel J, Grand’Maison F, Thibault M, Bhan V, Eliasziw M. Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes. Mult Scler 2013; 20:458-63. [DOI: 10.1177/1352458513501230] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background: The 2005 and 2010 McDonald criteria utilize magnetic resonance imaging (MRI) to provide evidence of disease dissemination in space (DIS) and time (DIT) for the diagnosis of multiple sclerosis (MS) in patients who have clinically isolated syndromes (CIS). Methods: Data from 109 CIS patients not satisfying the 2005 criteria at entry into a randomized controlled minocycline trial were analyzed to determine the proportion who would have been diagnosed with MS at screening based on 2010 criteria. The impact of including symptomatic, as well as asymptomatic, MRI lesions to confirm DIT was also explored. Results: Thirty percent (33/109) of patients, retrospectively, met the 2010 criteria for a diagnosis of MS at baseline. When both symptomatic and asymptomatic lesions were used to confirm DIT, three additional patients met the 2010 criteria. There was a significant 10.1% increase in the proportion of patients who met the 2010 DIS criteria, compared with the 2005 DIS criteria; however, two patients satisfied the 2005 DIS but not 2010 DIS criteria. Conclusion: Using 2010 McDonald criteria, 30% of the CIS patients could be diagnosed with MS using a single MRI scan. Inclusion of symptomatic lesions in the DIT criteria further increases this proportion to 33%.
Collapse
Affiliation(s)
- H Kang
- Department of Radiology, University of British Columbia (UBC), Canada
| | - LM Metz
- Department of Clinical Neurosciences, University of Calgary, Canada
| | - AL Traboulsee
- Division of Neurology, Department of Medicine, University of British Columbia, Canada
- UBC MS/MRI Research Group, Canada
| | - M Eliasziw
- Department of Public Health and Community Medicine, Tufts University, USA
| | - GJ Zhao
- Division of Neurology, Department of Medicine, University of British Columbia, Canada
- UBC MS/MRI Research Group, Canada
| | - Y Cheng
- Department of Radiology, University of British Columbia (UBC), Canada
- UBC MS/MRI Research Group, Canada
| | - Y Zhao
- Division of Neurology, Department of Medicine, University of British Columbia, Canada
- UBC MS/MRI Research Group, Canada
| | - DKB Li
- Department of Radiology, University of British Columbia (UBC), Canada
- Division of Neurology, Department of Medicine, University of British Columbia, Canada
- UBC MS/MRI Research Group, Canada
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|